Martin McCarter
Vice Chair of Strategic Planning and Program Development · University of Colorado School of Medicine
Credentials: · · · ·
History
1992–1999
1983–1987
Research
The Lancet · 2009 · 1,045 citations
Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2018 · 495 citations
Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2022 · 336 citations
39 papers
38 papers · 1 as a fellow
27 papers
26 papers
- RG
24 papers
22 papers
- KL
20 papers · 1 as a fellow
19 papers · 4 as a fellow
Grants
- 2020–2022
Improving Immunotherapies to Melanoma Through Modulation of MAIT Cell Activation by the Microbiome
National Cancer Institute · R21
Contact PI · $399.8K · University of Colorado Denver
- 2015–2018
Combined ATRA and Ipilimumab Treatment to Reduce Immunosuppression in Melanoma Patients
National Cancer Institute · R21
Contact PI · $372K · University of Colorado Denver
Clinical trials
- 2022–2026
Principal investigator · Active not recruiting · Phase 1, Phase 2
University of Colorado, Denver
- 2017–2022
Pembrolizumab and All-Trans Retinoic Acid Combination Treatment of Advanced Melanoma
Principal investigator · Completed · Phase 1, Phase 2
University of Colorado, Denver
- 2015–2023
Ipilimumab and All-Trans Retinoic Acid Combination Treatment of Advanced Melanoma
Principal investigator · Completed · Phase 2
University of Colorado, Denver